ErbB receptor regulation by dexamethasone in mouse type II epithelial cells

Area of Science:

• Pulmonary medicine
• Cellular signaling
• Endocrinology

Background:

• Glucocorticoids promote fetal lung surfactant synthesis, crucial for preventing preterm birth complications.
• Neuregulin (NRG) secreted by fibroblasts is a known mediator of glucocorticoid action on surfactant synthesis.
• The specific roles of erbB receptors in mediating these effects in fetal type II cells remain unclear.

Purpose of the Study:

• To investigate the effects of dexamethasone and NRG-containing fibroblast-conditioned medium (FCM) on erbB receptor signaling in fetal mouse lung type II cells.
• To elucidate the distinct mechanisms by which these agents influence surfactant synthesis and erbB receptor activation.

Main Methods:

• Cultured fetal mouse lung type II cells at different gestational ages (d16 and d17).
• Treated cells with dexamethasone and mature FCM.
• Assessed erbB receptor activation (phosphorylation), protein levels, dimerisation patterns, and surfactant synthesis.

Main Results:

• Dexamethasone inhibited surfactant synthesis in immature (d16) cells but stimulated it in mature (d17) cells.
• Mature FCM stimulated surfactant synthesis in both immature and mature cells.
• Dexamethasone increased erbB receptor protein levels and altered dimerisation (erbB2-erbB4), while FCM increased both protein levels and phosphorylation of erbB receptors and phospholipase Cgamma.

Conclusions:

• Dexamethasone and NRG-containing FCM utilize erbB receptors in fetal type II cells to regulate surfactant synthesis.
• Dexamethasone's signaling pathway is distinct from, though related to, NRG-mediated signaling, highlighting differential receptor modulation.